The FDA position The FDA labels for both semaglutide and tirzepatide neither recommend nor prohibit use during lactation
This is typically when appetite suppression, fat loss, and blood sugar benefits stabilize
Increased LPS activates TLR4-dependent inflammatory pathways
Decision guidance: If you have never used peptides before and your primary goal is hair restoration, topical GHK-Cu is the obvious starting point: strong mechanistic rationale, clinical evidence for follicle effects, excellent safety profile, no injections required, and commercially available in high-quality formulations
If retatrutide costs more, the breakeven calculation depends on how much additional weight loss is worth to the individual researcher
So, were not throwing the baby out with the bath water